The Role of Pretransplant Services on Outcomes and Costs in Kidney Transplantation
The Role of Pretransplant Services on Outcomes and Costs in Kidney Transplantation
批准号:
10575345
负责人:
Xingxing Shelley Cheng
金额:
$13.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2025-02-28
关键词:
AffectCaringCase MixesChronic Kidney FailureClinical InvestigatorCommunitiesCoronary ArteriosclerosisCost AnalysisCost SavingsDataDatabasesDiagnostic testsDialysis procedureEnd stage renal failureEnvironmentEvaluationExpenditureFee-for-Service PlansGrantHealthHealthcareHospital CostsHospitalizationInsurance CarriersInsurance CoverageKidneyKidney TransplantationLaboratoriesLinkLiving DonorsMaintenanceMedical SurveillanceMedicareMentored Patient-Oriented Research Career Development AwardMethodologyMinorityMyocardial IschemiaNephrectomyOrganOutcomePatientsPersonsPoliciesPopulationPractice GuidelinesPricePrivatizationProceduresProcessProviderQuality of CareReportingResearchRestRoleServicesTimeTrainingTransplant RecipientsTransplantationUnited StatesWagesWaiting Listscare coordinationcare costscomorbiditycostcost estimatecrosslinkeconometricsethnic minorityimprovedindexingliving kidney donormortalitypaymentprogramsracial minority populationscreeningsextransplant registry
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract
This R03 proposal is a supplement to the K23 proposal of Dr. Xingxing S. Cheng, MD MS. The purpose of Dr.
Cheng’s K23 is to refine the process of screening of coronary artery disease in patients with chronic kidney
disease on the waitlist for kidney transplantation. The purpose of this R03 proposal is to examine the entirety of
pretransplant services, of which coronary artery disease screening is a part, and their associations with
outcomes and costs. Medicare is currently paying, at cost, over 70% of the costs of pretransplant services,
including evaluation for addition to the waitlist, surveillance on the waitlist, and living donor evaluation and
procurement. These costs are reported by transplant programs to Medicare in the Organ Acquisition Cost
Center (OACC). The proposed research will crosslink two databases in which Dr. Cheng’s team have already
demonstrated expertise at a program-year (not individual patient) level: 1) OACC cost data from the Hospital
Cost Report and 2) aggregated program-year data from the Scientific Registry of Transplant Recipients
(SRTR). The two aims of the proposal will be to assess the association of the quantity of pretransplant services
with 1) pretransplant outcomes (quality) and 2) costs.
The proposed research expands the scope of Dr. Cheng’s K23 award to the broad range of pretransplant care,
and provides Dr. Cheng with the opportunity for more econometric training. The proposed research will an
empirical overview of the relative distribution of costs and value among the types of pretransplant services and
create a rich database of pretransplant services, outcomes, and costs at a transplant program-level. A next-
step R01 grant will evaluate potential policy and practice guideline changes for pretransplant care on the basis
of value. This R03 will therefore supplement the K23 award to enable Dr. Cheng to become a successful
independent clinical investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Refining repeat screening for coronary artery disease in kidney transplant candidates
-
批准号:10386877
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2020
-
负责人:Xingxing Shelley Cheng
-
依托单位:
Refining repeat screening for coronary artery disease in kidney transplant candidates
-
批准号:10189578
-
项目类别:
-
资助金额:$16.57万
-
财政年份:2020
-
负责人:Xingxing Shelley Cheng
-
依托单位:
Refining repeat screening for coronary artery disease in kidney transplant candidates
-
批准号:10591532
-
项目类别:
-
资助金额:$16.47万
-
财政年份:2020
-
负责人:Xingxing Shelley Cheng
-
依托单位:
海外基金